| ORIGINAL ARTICLE |
![]() |
![]() |
Background. Nowadays, there is an increasing number of infectious diseases in humans and animals associated with formation of microbial biofilms, including fungal-bacterial consortia. Due to the diffusional barrier of the biofilm matrix, the biofilm-embedded cells are characterized by increased resistance to antimicrobials and the host immune system. In this study we assessed the ability of diiod derivatives of BODIPY luminophores to eradicate mono- and dual species communities of S. aureus and C. albicans.
Results. The diiodo-BODIPY meso-butanoic acid, and its conjugate with isobornanethioethyl or pinanyl, were tested. The diiod derivative of BODIPY in the form of acid, when irradiated at 530 nm at concentrations of 2 μg/ml, resulted in complete cell death of planktonic staphylococci, and at 16 μg/ml completely eradicated its biofilm, but was non effective against Candida biofilms. Partial cell death was observed against S. aureus in mixed S. aureus and C. albicans biofilms at 8 μg/ml. The compound was able to penetrate biofilms as resolved by CLSM, but moderate antimicrobial activity was observed.
Conclusion. The diiod-BODIPY acid of BODIPY luminophores are of interest for photodynamic therapy of staphylococcal biofilms. Their conjugation with terpenoids increases the rate of biofilm penetration, but the selection of a terpene radical is necessary to enhance antimicrobial activity.
Key words: bacterial biofilms, photodynamic therapy, terpenoids, BODIPY